Walleye Capital

Walleye Capital’s Fractyl Health GUTS Stock Holding History

Walleye Capital’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-592,125	Closed	-$1.3M	–	5091
2025 Q4	$1.3M	Buy	+592,125	New	+$953K	﹤0.01%	2215

Other funds holding GUTS

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Walleye Capital's GUTS Position: Q1 2026 in Review

Walleye Capital sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 592,125 shares — an estimated $1.3M sold.

Walleye Capital first reported a position in GUTS in Q4 2025 and held it in 1 quarter. The position peaked at $1.3M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

Walleye Capital reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
Walleye Capital sold 592,125 Fractyl Health shares in Q1 2026, an estimated $1.3M.
Walleye Capital first reported a position in Fractyl Health in Q4 2025 and held it in 1 quarter.
Walleye Capital's Fractyl Health position peaked at $1.3M in Q4 2025.
83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.